CA
SPPI

CoreCap Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

CoreCap Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$9 Buy
+24
New +$10 ﹤0.01% 2381
2022
Q3 		– Sell
-24
Closed – – 2275
2022
Q2 		$0 Buy
+24
New +$21 ﹤0.01% 2334
2022
Q1 		– Sell
-24
Closed -$1K – 2272
2021
Q4 		$1K Buy
+24
New +$43 ﹤0.01% 2341

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

CoreCap Advisors's SPPI Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022: 24 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #2381 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in SPPI as recently as Q2 2022.

CoreCap Advisors first reported a position in SPPI in Q4 2021 and has held it in 3 quarters since. The position peaked at $1K in Q4 2021. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • CoreCap Advisors held 24 shares of Spectrum Pharmaceuticals Inc worth $9 as of Q4 2022.
  • Spectrum Pharmaceuticals Inc was a new CoreCap Advisors position in Q4 2022.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2381 holding.
  • CoreCap Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2021 and has held it in 3 quarters since.
  • CoreCap Advisors's Spectrum Pharmaceuticals Inc position peaked at $1K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.